— Know what they know.
Not Investment Advice

RLYB NASDAQ

Rallybio Corporation
1W: +2.8% 1M: +0.8% 3M: +8.7% YTD: +201.8% 1Y: +3191.6% 3Y: +385.2% 5Y: +22.9%
$17.08
+0.32 (+1.91%)
 
Weekly Expected Move ±3.9%
$16 $16 $17 $18 $18
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 56 · $90.6M mcap · 3M float · 2.41% daily turnover · Short 23% of daily vol

📊 Key Metrics

TTM
$1M
Revenue
-15.1% YoY
$46M
Net Income
+209.4% YoY
$26M
Free Cash Flow
+162.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE64.9%
ROA61.1%
ROIC-1399.7%

Valuation

P/E2.2
P/B1.0
EV/EBITDA-0.0

Leverage

Debt/Equity0.00
Current Ratio27.26
Interest Cov.0.0x

Quality Scores

Piotroski F6/9
Altman Z13.86
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms